BioMed Research International
Volume 2019 (2019), Article ID 4562385, 10 pages
https://doi.org/10.1155/2019/4562385

Review Article

Prevalence of Syphilis among Pregnant Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis

Siraj Hussen¹ and Birkneh Tilahun Tadesse²

¹School of Laboratory Science, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia
²Department of Pediatrics and Child Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia

Correspondence should be addressed to Birkneh Tilahun Tadesse; birknehtilahun@gmail.com

Received 17 April 2019; Revised 20 June 2019; Accepted 27 June 2019; Published 16 July 2019

Academic Editor: Lucia Lopalco

Copyright © 2019 Siraj Hussen and Birkneh Tilahun Tadesse. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. Syphilis is one of the most imperative STIs, caused by the spirochete Treponema pallidum. During pregnancy it is associated with disastrous health outcomes in the newborn. In sub-Saharan Africa, study findings on the prevalence of syphilis among pregnant women are highly dispersed and inconsistent. The aim of the current review is to conduct a systematic review and meta-analysis of syphilis in sub-Saharan Africa among pregnant women. Design. Systematic review and meta-analysis. Data Sources. Databases including MEDLINE, PubMed, Cochrane Library, Google Scholar, and HINARI and reference lists of previous prevalence studies were systematically searched for relevant literature from January 1999 to November 2018. Results were presented in forest plot, tables, and figures. Random-effects model was used for the meta-analysis. For the purpose of this review, a case of syphilis was defined as positive treponemal or nontreponemal tests among pregnant women. Data Extraction. Our search gave a total of 262 citations from all searched databases. Of these, 44 studies fulfilling the inclusion criteria and comprising 175,546 subjects were finally included. Results. The pooled prevalence of syphilis among pregnant women in sub-Saharan Africa was 2.9% (95%CI: 2.4%-3.4%). East and Southern African regions had a higher syphilis prevalence among pregnant women (3.2%, 95% CI: 2.3%-4.2% and 3.6%, 95%CI: 2.0%-5.1%, respectively) than the sub-Saharan African pooled prevalence. The prevalence of syphilis among pregnant women in most parts of the region seemed to have decreased over the past 20 years except for the East African region. However, prevalence did not significantly differ by region and time period. Conclusion. This review showed a high prevalence of syphilis in sub-Saharan Africa among pregnant women. The evidence suggests strengthening the screening program during pregnancy as part of the care package during antenatal care visits. Programs focusing on primary prevention of syphilis in women should also be strengthened.

1. Introduction

Syphilis is one of the most imperative STIs, caused by the spirochete Treponema pallidum and it is a significant public health issue, especially in developing countries including sub-Saharan Africa [1]. More than 10 million people are infected with syphilis worldwide; the majority of these infections occur in sub-Saharan Africa and Asia [2]. Annually, around 2 million pregnant women are estimated to have active syphilis infection while only less than one-tenth would be diagnosed and receive the treatment. More than 90% of these infections occur in resource limited settings [3–5].

The prevalence of syphilis infection among pregnant women in sub-Saharan Africa is estimated to be 2.7%, which represents nearly 1 million pregnancies to be at risk annually [6]. In the United States, recent data show that more than 30,000 cases of primary and secondary syphilis infection were reported [7]. Unfavorable pregnancy outcomes were reported to be more than four times higher in untreated syphilis infection among pregnant women as compared to pregnant women without syphilis infection [8].

Syphilis is transmitted via sexual contact or from mother to child during pregnancy or at delivery [9]. During pregnancy, syphilis infection might also increase the risk of mother-to-child transmission of HIV in cases where mothers are coinfected [10]. Syphilis in pregnancy which is not treated properly was reported to cause poor pregnancy outcomes in about half of the cases—stillbirths in 40%, deaths and neonatal morbidity in 20%, and small birth weight deliveries in 20% [11–13].

In 2016, the WHO strategy on global health sector outlines the control and prevention of sexually transmitted infections (STI). The goal of the global health sector strategy is to reduce the incidence of syphilis by 90% and congenital syphilis to <50 cases per 100,000 live births in the coming decade [14]. To support implementation and assess progress towards the target of these strategies, understanding the pooled estimates of prevalence of these infections by region and subregion would help to guide clinical decision making, public resource allocation, and optimization of intervention protocols. Currently, different studies done in the region reveal a considerable variation in the prevalence of syphilis among pregnant women including geography and time. Overall, there is lack of a recently summarized data on syphilis among pregnant women in the region. The current review and meta-analysis aims to provide updated information on syphilis infection during pregnancy and pooled estimates of the prevalence of syphilis among pregnant women.

2. Methods

2.1. Search Strategy

A systematic literature search was conducted on the prevalence syphilis in sub-Saharan Africa. Relevant citations were identified through a literature search of MEDLINE, PubMed, HINARI, Google Scholar, and Cochrane Library. The search was based on the combination of the following special index search terms using medical subject headings (MeSH) and Boolean operations: “sexually transmitted infections” OR “sexually transmitted diseases” OR “genital tract infections” OR “reproductive tract infections” OR “syphilis” OR “Treponema palladium” and “pregnancy” OR “pregnant women” OR “antenatal” OR “prenatal care” and “developing country” OR “Africa” “Lists of particular countries in Sub-Saharan Africa” and “prevalence” OR “epidemiology” from January 1999 to November , 2018. Literature search was limited to published studies among humans in English language. All records were managed in Endnote version of X7 (Clarivate Analytics, Philadelphia, PA, USA) and duplicated studies were carefully removed. The search was carried out from April , 2018 to November 20, 2018. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline [15] was used to report the result of this systematic review and meta-analyses (Table S1).

2.2. Selection Criteria

Abstracts retrieved from the initial search were screened using defined inclusion and exclusion criteria.

2.3. Inclusion Criteria and Exclusion Criteria

Studies were selected for systematic review and meta-analysis if (1) they were conducted in sub-Saharan Africa, (2) study design was cross-sectional, (3) studies reported the prevalence of syphilis, and (4) studies reported data in humans and were published in the English language.

Studies were examined for eligibility by reading their titles and abstracts. Relevant abstracts were further assessed for inclusion in the list of full text articles. During the article selection process, studies which did not have full texts were excluded since it was not possible to assess the quality of each article in the absence of their full texts.

2.3.1. Case Definition of Syphilis

In the current review, a case of syphilis was considered when one or more of TPHA (Treponema Hemagglutination), EIA (Enzyme Immunoassay), VDRL (Venereal Disease Research Laboratory), RPR (Rapid Plasma Reagin), ELISA (Enzyme Linked Immunosorbent Assay), or RICT (Rapid Immunochromatographic test) were positive among pregnant women. All articles which used treponemal (TPHA, EIA), nontreponemal (VDRL and RPR), or other tests to make a diagnosis of syphilis were included in the review.

2.4. Data Extraction

Two researchers (SH and BTT) independently extracted the data from included studies using a standardized and pretested format prepared in Microsoft Excel. The data abstraction format included first author, study design, region in sub-Saharan Africa, publication year, sample size, study population, number of individuals who tested positive, and prevalence of syphilis. Disagreement on data extractions between researchers was resolved through discussion and consensus.

2.5. Quality Assessment

The quality of each article was assessed using 9 point Joanna Briggs Institute (JBI) critical appraisal tools. The tool uses the following criteria.

(1) Was the sample frame appropriate to address the target population? (2) Were study participants sampled in an appropriate way—was sampling method appropriate to the design? (3) Was the sample size adequate—have the authors used appropriate assumptions to calculate sample size? (4) Were the study subjects and the setting described in detail? (5) Was the data analysis conducted with sufficient coverage of the identified sample as coverage bias can occur when not all subgroups of the identified sample respond at the same rate? (6) Were valid methods used for the identification of the condition? (7) Was the condition measured in a standard, reliable way for all participants? (8) Was there appropriate statistical analysis? (9) Was the response rate adequate?

Individual studies were assigned a score that was computed using different parameters in line with the review objectives. The responses were scored 0 for “Not appropriate and not reported” and 1 for “Yes”. Total scores ranged between 0 and 9. Studies with medium (fulfilling 50% of quality assessment parameter) and high quality were included for analysis [16]. All the studies scored at least 50% and none of them were excluded based on the quality assessment criteria (Table S2).

2.6. Statistical Analysis

The data analyses were done using STATA (version.14.0) software. Forest plot, figures, and tables were used to describe the included original articles. A random effect model was used to compute the pooled prevalence of syphilis as there was heterogeneity among studies. The estimated pooled prevalence was presented with 95% confidence interval (CI).

2.7. Subgroup Analysis

Subgroup analysis was performed based on region (East, West, Central,and Southern Africa) and year of study (1999-2003, 2004-2008, 2009-2013, and 2014-2018).

2.8. Heterogeneity and Publication Bias

Cochran’s Q test and statistic were used to assess statistical heterogeneity. values 25%, 50%, and 75% are classified as low, medium, and high heterogeneity, respectively [17, 18]. We used random-effects meta-analysis to estimate the pooled prevalence with 95% CI as the >25%. Cochran’s Q test–p < 0.10 was used to verify the existence of statistical heterogeneity. To assess publication bias, Begg intercept statistics test was used; a p value < 0.05 suggests presence of a statistically significant publication bias [19].

3. Results

3.1. Identified Studies

A total of 262 citations were retrieved through electronic database search. Of these, 212 were excluded based on screening of titles and abstracts. From the remaining fifty articles, six articles were excluded (three articles are not cross-sectional studies and three have no prevalence data). Finally, 44 studies were found to be eligible and were included in the meta-analysis (Figure 1). Because of the high heterogeneity observed across studies (Q=3930.11, p <0.0001; I²= 98.9% and Tau-squared, p= 2.269), a random-effects model was used for the meta-analysis. Eggers regression intercept test indicated no evidence of publication bias (p =0.154) (Figure 3).

Figure 1: Flow diagram of studies reviewed, screened, and included.

3.2. Study Characteristics

A total of 44 studies were considered eligible for quantitative syntheses (Table 1). Included articles were published from 1999 to 2018 across sub-Saharan Africa—East, West, Central, and Southern Africa. The total number of study subjects involved in the systematic review and meta-analysis was 175,546. From the total study population, regional study populations included in the review were 80 809 from Eastern region, 43 480 from West Africa region, 25 811 from Central Africa region, and 26 046 from Southern Africa. The study population among individual studies varied from 165 to 39 698 and were conducted between the years 1999 to 2018 (Table 1). All studies utilized blood specimens for diagnosis of syphilis (Table 1). All the included studies utilized data which were collected from health facilities. The reported prevalence of syphilis among pregnant women ranged from 0 to 22.1%. RPR, TPHA ICT, and ELISA were used for the diagnosis of syphilis infection (Table 1).

Table 1: General characteristics of the included studies in systematic review and meta-analysis from 1999 to 2018.

Author & ref.
Pub. year
Study area
Sample size
Number(%)
Specimen
DX. methods
Qua (9%)

Kebede & Chamso, [20]
2000
Ethiopia
410
12(2.9)
Blood
VDRL
7

Mulu et al., [21]
2007
Ethiopia
480
5(1.0)
Blood
RPR&TPHA
7

Tiruneh, [22]
2008
Ethiopia
480
11(2.3)
Blood
RPR &TPHA
7

Ramos et al., [23]
2011
Ethiopia
165
0(0.0)
Blood
ELISA
5

Assefa, [24]
2014
Ethiopia
2385
69(2.9)
Blood
RPR& TPHA
8

Endris et al., [25]
2015
Ethiopia
385
11(2.9)
Blood
RPR& TPHA
8

Melku et al., [26]
2015
Ethiopia
300
11(3.7)
Blood
RPR&TPHA
8

Deme [27]
2016
Ethiopia
574
2(0.3)
Blood
RPR
7

Fissehatsion et al., [28]
2017
Ethiopia
403
0(0.0)
Blood
RICT
8

Zinabie et al., [29]
2018
Ethiopia
385
7(1.8)
Blood
VDRL
8

Schönfeld et al., [30]
2018
Ethiopia
580
13(2.2)
blood
RICT
7

Taiwo etal., [31]
2007
Nigeria
505
50(9.9)
Blood
RPR&TPHA
6

Bukar et al., [32]
2009
Nigeria
18101
9(0.1)
Blood
RPR&TPHA
7

Aboyeji [33]
2009
Nigeria
230
4(1.7)
Blood
RPR
6

Buseri et al., [34]
2010
Nigeria
1000
50(5.0)
Blood
RICT &TPHA
5

Mbamora et al., [35]
2011
Nigeria
1393
8(0.6)
Blood
ELISA&TPHA
7

ISA et al., [36]
2014
Nigeria
108
2(1.9)
Blood
RICT
6

Olowe et al., [37]
2014
Nigeria
394
8(2.0)
Blood
RPR&TPHA
5

Dionne-Odomet al., [38]
2016
Cameron
7069
120(1.7)
Blood
RICT
7

De Paschaleet al., [39]
2014
Benin
283
7(2.5)
Blood
EIA
5

Kinoshita et al., [40]
2008
DRC
529
0(0.0)
Blood
RPR&TPHA
6

Taylor et al., [41]
2014
DRC
17669
742(4.2)
Blood
RICT &RPR
8

Berrueta et al., [42] D
2017
DRC
4153
17(0.4)
Blood
RICT
5

Niama et al., [43]
2017
DRC
2979
117(3.9)
Blood
RPR
7

Emanuael et al., [44]
2010
Sudan
231
51(22.1)
Blood
RPR
9

Abdelrahim et al., [45]
2017
Sudan
426
21(5.0)
Blood
RPR
6

Elkheir et al., [46]
2018
Sudan
444
33(7.4)
Blood
RICT
9

Pham et al., [47]
2005
Zimbabwe
2969
143(4.8)
Blood
RPR
8

Kurewa et al., [48]
2010
Zimbabwe
691
8(1.2)
Blood
RPR&TPHA
9

Kwiek et al., [49]
2008
Malawi
3824
191(5.0)
Blood
RPR&TPHA
8

Sombié et al., [50]
2000
Burkina Faso
10980
26(0.2)
Blood
RPR &TPHA
9

Kirakoya et al., [51]
2011
Burkina Faso
2136
64(3.0)
Blood
RPR
5

Urassa et al., [52]
2001
Tanzania
1058
62(5.9)
Blood
VDRL&TPHA
7

Swai et al., [53]
2006
Tanzania
17323
1265(7.3)
Blood
RPR
8

Yahya et al., [54]
2008
Tanzania
1296
21(1.6)
Blood
RPR&TPHA
9

Manyahi et al., [55]
2015
Tanzania
39698
992(2.5)
Blood
RPR
7

Lawi et al., [56]
2015
Tanzania
331
9(2.7)
Blood
RPR& RICT
8

Manson et al., [57]
2010
Guinea
711
7(1.0)
Blood
RPR
6

Apea-Kubi et al., [58]
2004
Ghana
570
32(5.6)
Blood
TPHA
6

Blankhart et al., [59]
1999
CAR
481
32(6.7)
Blood
RPR
8

Gichangi et al., [60]
2004
Kenya
12414
372(3.0)
Blood
RPR
6

Marx et al., [61]
2010
Kenya
441
13(3.0)
Blood
RPR&TPHA
9

Romoren, [62]
2006
Botswana
465
23(5.0)
Blood
RPR&TPHA
6

Berrueta et al., [42] Z
2017
Zambia
18097
398(2.2)
Blood
RPR
5

RPR=rapid plasma regain, TPHA=treponema palladium hama agglutination inhibition test, VDRL=venereal disease research laboratory, RICT= rapid immunochromatography test, Pub-year=publication year, Ref=reference, CAR=Central African Republic, DRC=Democratic Republic of Congo.

3.3. Meta-Analysis of Syphilis

The analysis of 44 studies, according to the Der Simonian-Laird random-effects model, revealed that the pooled prevalence of syphilis in sub-Saharan Africa was 2.87% (95% CI: 2.38-3.35) (Figure 2). Pooled prevalence of syphilis varied by region—2.17% (95% CI: 2.06-2.29) for Eastern Africa, 0.16% (95% CI: - 0.12-0.20) for Western Africa, 1.04% (95%CI: 0.52-1.17) for Central Africa, and 2.49% (95%CI: 2.31-2.68) for Southern Africa (Figure S1 and Table 2), while grouping the pooled prevalence was by every five years—0.29% (95% CI: 0.19-0.39) during 1999-2003, 2.12% (95% CI: 1.97-2.26) during 2004-2008, 0.09% (95%CI: 0.04-0.14) during 2009-2013, and 1.72% (95% CI: 1.63-1.81) during the 2014-2018 period (Figures S2 and S3 and Table 2). In addition, we performed a metaregression analysis to identify the possible sources of heterogeneity, by considering different factors associated with the heterogeneity, such as publication year geographic region and diagnostic tests, but none of these variables was found to be statistically significant. The prevalence of syphilis showed a decreasing trend in Southern, Central, and West African regions but showed a similar trend in the Eastern African region (Figure 4). The subgroup analysis was done on the prevalence of syphilis by type of diagnostic test: nontreponemal test (NTT): RPR&VDRL; treponemal test (TT): TPHA&EIA; and point of care test (POT): ICT. Pooled prevalence of syphilis was 3.77% (95%CI: 2.83–4.71) using NTT; 2.23% (95%CI: 1.77–2.68) using NTT and TT; 0.63% (95%CI: 0.18–1.43) using TT; 2.33% (95%CI: 0.93–3.72) using POT; and 3.91% (95%CI: 1.66–6.16) using POT&TT (Table 2 and Figure S3).

Table 2: Subgroup meta-analysis of syphilis prevalence in sub-Saharan Africa from 1999 to 2018.

Categories
Subgroup
No. of studies included
Pre. (%) (95% CI
I²

Region
East Africa
21
3.25(2.24-4.25)
98.4

West Africa
13
1.86(1.39-2.32)
96.5

Central Africa
5
2.85(1.02-4.68)
99.4

Southern Africa
5
3.35(2.04-5.09)
96.2

Year of study
1999-2003
4
3.86(0.36-7.36)
97.0

2004-2008
11
4.05(2.18-5.91)
99.2

2009-2013
10
2.07(1.18-2.97)
95.9

2014-2018
19
2.47(2.38-3.35)
97.8

Serologic tests
NTT
16
3.77 (2.83-4.71)
98.2

NTT & TT
16
2.23 ( 1.77-2.68)
96.9

TT
3
0.63(0.18-1.43)
75.3

POT
7
2.33 (0.93-3.72)
99.0

POT & TT
2
3.91(1.66-6.16)
98.9

NB: TT=treponemal test, NTT= nontreponemal test, POT= point of care test, CI = confidence interval.

Figure 2: The meta-analysis and forest plot of prevalence of syphilis from 1999 to 2018.

Figure 3: Funnel plot of standard error by logit event rate.

Figure 4: Pattern of the prevalence of syphilis in the four subregions in sub-Saharan Africa from 1999 to 2018.

4. Discussion

Syphilis is one of the easily preventable and treatable sexually transmitted infections but continues to exert a high burden worldwide especially in sub-Saharan Africa. Prevention and control of syphilis is crucial for pregnant women. Antenatal care (ANC) follow-up screening plays a great role in diagnosing syphilis early. However, the actual burden of syphilis infection during pregnancy is not well known especially in resource poor settings where diagnosis is made based on clinical signs and symptoms, short of diagnostic laboratory tests. Clinical diagnosis of syphilis infection is subject to underestimating the real burden as clinically asymptomatic cases would be unaccounted for.

The current meta-analysis estimated the pooled prevalence of syphilis, 2.87% (95% CI: 2.38-3.35) in sub-Saharan Africa using 44 studies. Similar prevalence (2.7%) was reported in a previous systematic review conducted in sub-Saharan Africa among pregnant women [63]. However, studies reported a higher prevalence of syphilis infection in East and South African regions (4.5%) [64], among incarcerated women (6.10%) [65] and among aboriginal populations in Australia (16.8%) [66]. The differences in the prevalence of syphilis mainly reflect the risk profiles of the populations included in the studies. Moreover, the findings indicate that certain regions in sub-Saharan Africa exhibit a particularly higher prevalence of syphilis.

The current review also showed that the prevalence of syphilis infection during pregnancy has remained to be high in the East African region. Similar rise in the prevalence of syphilis has been reported from the developed world [7]. The persistently high prevalence of syphilis in East Africa could be related to affordability of cost for screening and the relatively weekly ANC follow up [67], unavailability of treatment or reinfection from an untreated sexual partner [68]. The high prevalence of syphilis in the region is a particular concern as syphilis infection during pregnancy frequently leads to unfavorable pregnancy outcomes including fetal/neonatal mortality and morbidity because of congenital syphilis.

Even though a decreasing trend was observed, the prevalence of syphilis infection during pregnancy was the highest in Southern Africa followed by East Africa. The prevalence in this region was fifteen times higher than that of West Africa, even though the number of identified studies in Southern Africa was small further limiting the scope of the review to understand the true prevalence in the region. Similarly, a high prevalence of syphilis infection during pregnancy was reported from East and South Africa [64]. The regional differences in the prevalence of syphilis infection in pregnant women could be because of differences in the strength of programs for primary prevention, quality of ANC follow-up programs and availability of diagnostic and therapeutic interventions in the health system.

Higher pooled prevalence of syphilis was reported by NTT tests. Pooled prevalence of syphilis during pregnancy by using studies which used TT tests for the diagnosis was low. This could be possibly explained by the high sensitivity and lower specificity of NTT test for the diagnosis of syphilis infection. The high pooled prevalence by NTT may be due to false-positive reactions related to either acute or chronic infection. False-positive reactions to NTT tests could be due to several acute and chronic disorders including acute febrile illnesses, vaccination, pregnancy itself, connective tissue disorders, cancer, Chagas disease, or tuberculosis [69, 70].

The current review and meta-analysis used data from urban populations who have better access to preventive and therapeutic programs and services for syphilis infection. This may underestimate the real burden of syphilis infection in the rural population of pregnant women. Moreover, most of studies which were included in the analysis were facility based studies, and the data might not be representative of population/community-based prevalence of syphilis among pregnant women. As diagnostic tests are usually applied for women who have symptoms, the current prevalence could be considered as an underestimation because of unavailability of studies targeting asymptomatic individuals to enable a more accurate estimation of prevalence of syphilis. Furthermore, as the included studies used different diagnostic tests which have varying sensitivity and specificity, heterogeneity of the results might have biased the true estimate of syphilis in the region. Additionally, the review protocol for the current review has not been registered online and could be considered as a limitation. As any disagreements between the reviewers were resolved through discussion, agreement between the reviewers was not assessed using the Cohens Kappa coefficient which might have limited objectivity.

In conclusion, the current review revealed that prevalence of syphilis among pregnant women is high in sub-Saharan Africa. The prevalence is particularly high in the Southern and East African regions. The review highlights that syphilis infection during pregnancy is still a high burden necessitating implementation of programs that can facilitate primary prevention and also intensify diagnosis and treatment of pregnant mothers diagnosed with syphilis.

Data Availability

No additional data are available.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Siraj Hussen conceived the idea, participated in data collection, and wrote the first draft of the manuscript. Birkneh Tilahun Tadesse contributed during data analysis and manuscript writing. Both authors read and approved the final manuscript.

Supplementary Materials

Table S1 presents PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Table S2 shows the study design and quality assessment of the studies included in systematic review and meta-analysis of syphilis in sub-Saharan Africa. Figure S1 represents the subgroup meta-analysis by geographical region. The forest plot presentation indicates the prevalence of syphilis from 1999 to 2018 in each region, whereas Figure S2 shows the subgroup meta-analysis by year of study. The forest plot indicates the prevalence of syphilis during each 5-year period. Figure S3 presents the subgroup meta-analysis by laboratory diagnostic test. The forest plot shows the prevalence of syphilis by each diagnostic test from 1999 to 2018. Metareg S1 presents the metaregression outputs for the estimates. Syntax S2 presents the syntax used for the search of databases. (Supplementary Materials)

References

U. UNAIDs and W. H. Organization, “Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report,” Tech. Rep., November 2011.

W. A. Lynn and S. Lightman, “Syphilis and HIV: a dangerous combination,” The Lancet Infectious Diseases, vol. 4, no. 7, pp. 456–466, 2004.

L. Arnesen, G. Martínez, L. Mainero, S. Serruya, and P. Durán, “Gestational syphilis and stillbirth in Latin America and the Caribbean,” International Journal of Gynecology and Obstetrics, vol. 128, no. 3, pp. 241–245, 2015.

C. E. Cameron and S. A. Lukehart, “Current status of syphilis vaccine development: Need, challenges, prospects,” Vaccine, vol. 32, no. 14, pp. 1602–1609, 2014.

R. M. S. M. Domingues, V. Saracen, Z. M. D. A. Hartz, and M. D. Leal, “Sífilis congênita: evento sentinela da qualidade da assistência pré-natal,” Revista de Saúde Pública, vol. 47, no. 1, pp. 147–157, 2013.

WHO, “Baseline report on global sexually transmitted infection surveillance 2012,” Tech. Rep., 2013.

J. Braxton, D. W. Davis, B. Emerson et al., “Sexually transmitted disease surveillance 2017,” Tech. Rep., 2018.

World Health Organization, “Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates,” Tech. Rep., World Health Organization, Geneva, Switzerland, 2001.

G. B. Gomez, M. L. Kamb, L. M. Newman, J. Mark, N. Broutet, and S. J. Hawkes, “Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis,” Bulletin of the World Health Organization, vol. 91, no. 3, pp. 217–226, 2013.

D. T. Fleming and J. N. Wasserheit, “From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection,” Sexually Transmitted Infections, vol. 75, no. 1, pp. 3–17, 1999.

S. J. Hawkes, G. B. Gomez, and N. Broutet, “Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? a systematic review and meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e56713, 2013.

G. P. Schmid, B. P. Stoner, S. Hawkes, and N. Broutet, “The need and plan for global elimination of congenital syphilis,” Sexually Transmitted Diseases, vol. 34, no. 7, pp. S5–S10, 2007.

S. Mullick, D. Watson-Jones, M. Beksinska, and D. Mabey, “Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries,” Sexually Transmitted Infections, vol. 81, no. 4, pp. 294–302, 2005.

World Health Organization, Global Health Sector Strategy on Sexually Transmitted Infections 2016-2021: Toward Ending STIs, 2016.

A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” PLoS Medicine, vol. 6, no. 7, Article ID e1000100, 2009.

“JBI Critical Appraisal Checklist for Studies Reporting Prevalence Data,” 2016.

R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986.

G. Rücker, G. Schwarzer, J. R. Carpenter, and M. Schumacher, “Undue reliance on I2 in assessing heterogeneity may mislead,” BMC Medical Research Methodology, vol. 8, no. 1, article no. 79, 2008.

J. P. A. Ioannidis, “Interpretation of tests of heterogeneity and bias in meta-analysis,” Journal of Evaluation in Clinical Practice, vol. 14, no. 5, pp. 951–957, 2008.

E. Kebede and B. Chamso, “Prevalence of syphilis in pregnancy in Addis Ababa,” East African Medical Journal, vol. 77, no. 4, 2009.

A. Mulu, A. Kassu, B. Tessema et al., “Seroprevalence of syphilis and HIV-1 during pregnancy in a teaching hospital in northwest Ethiopia,” Japanese Journal of Infectious Diseases, vol. 60, no. 4, pp. 193–195, 2007.

M. Tiruneh, “Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia,” Ethiopian Medical Journal, vol. 46, no. 4, pp. 359–366, 2008.

J. M. Ramos, C. Toro, F. Reyes, A. Amor, and F. Gutiérrez, “Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia,” Journal of Clinical Virology, vol. 51, no. 1, pp. 83–85, 2011.

A. Assefa, “A three year retrospective study on seroprevalence of syphilis among pregnant women at Gondar University Teaching Hospital, Ethiopia,” African Health Sciences, vol. 14, no. 1, pp. 119–124, 2014.

M. Endris, T. Deressa, Y. Belyhun, and F. Moges, “Seroprevalence of syphilis and human immunodeficiency virus infections among pregnant women who attend the University of Gondar teaching hospital, Northwest Ethiopia: A cross sectional study,” BMC Infectious Diseases, vol. 15, no. 1, article no. 111, 2015.

M. Melku, A. Kebede, and Z. Addis, “Magnitude of HIV and syphilis seroprevalence among pregnant women in gondar, northwest ethiopia: a cross-sectional study,” HIV/AIDS—Research and Palliative Care, vol. 7, pp. 175–182, 2015.

C. Deme, B. Edao, G. Jaya et al., “Prevalence of hypertension, anemia, asymptomatic urinary tract infection, syphilis, hiv and hepatitis b virus infection among pregnant women attending an antenatal clinic at a rural hospital in Southern Ethiopia,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 47, no. 5, pp. 1032–1039, 2016.

K. Fissehatsion, I. Ali, and A. Getachew, “Seroprevalence and risk factors of sexually transmitted infections (HIV, HBV and Syphilis) among pregnant women provided health care services, Addis Ababa, Ethiopia,” American Journal of Health Research, vol. 5, no. 5, pp. 154–161, 2017.

S. Zinabie, E. Belachew, T. Yidenek et al., “Sero-prevalence of syphilis and HIV and associated factors in pregnant women attending antenatal care clinics in Debre Berhan Public Health Institutions, Ethiopia,” American Journal of Biomedical and Life Sciences, vol. 6, no. 3, pp. 56–62, 2018.

A. Schönfeld, T. Feldt, T. B. Tufa et al., “Prevalence and impact of sexually transmitted infections in pregnant women in central Ethiopia,” International Journal of STD & AIDS, vol. 29, no. 3, pp. 251–258, 2018.

S. S. Taiwo, Y. O. Adesiji, and D. A. Adekanle, “Screening for syphilis during pregnancy in Nigeria: a practice that must continue,” Sexually Transmitted Infections, vol. 83, no. 5, pp. 357-358, 2007.

M. Bukar, B. M. Audu, U. I. Takai, B. B. Ajayi, and A. A. Kullima E, “Is routine antenatal screening for syphilis in Nigeria still justified clinically and economically?” Saudi Medical Journal, vol. 30, no. 10, pp. 1311–1315, 2009.

A. Aboyeji and C. Nwabuisi, “Prevalence of sexually transmitted diseases among pregnant women in Ilorin, Nigeria,” Journal of Obstetrics & Gynaecology, vol. 23, no. 6, pp. 637–639, 2003.

F. Buseri, E. Seiyaboh, and Z. Jeremiah, “Surveying infections among pregnant women in the Niger Delta, Nigeria,” Journal of Global Infectious Diseases, vol. 2, no. 3, p. 203, 2010.

S. U. Mbamara and N. J. Obiechina, “Seroprevalence of venereal disease among pregnant women attending antenatal care (ANC) in Onitsha, Anambra State, Southeast, Nigeria,” Nigerian Journal of Medicine : Journal of the National Association of Resident Doctors of Nigeria, vol. 20, no. 1, pp. 57–60, 2011.

M. Isa, H. Bello, A. Mustapha et al., “Prevalence of syphilis among pregnant women attending State Specialist Hospital Maiduguri, Borno, Nigeria,” International Journal of Research, vol. 1, no. 11, pp. 523–530, 2014.

O. Olowe, O. Makanjuola, R. Olowe, J. Olaitan, O. Ojurongbe, and S. Fadiora, “Prevalence of syphilis among pregnant women in two health care facilities in South Western Nigeria,” British Journal of medicine and Medical Research, vol. 4, no. 34, pp. 5431–5438, 2014.

J. Dionne-Odom, R. Mbah, N. J. Rembert et al., “Hepatitis B, HIV, and Syphilis Seroprevalence in pregnant women and blood donors in Cameroon,” Infectious Diseases in Obstetrics and Gynecology, vol. 2016, Article ID 4359401, 8 pages, 2016.

M. De Paschale, C. Ceriani, T. Cerulli et al., “Antenatal screening for Toxoplasma gondii, Cytomegalovirus, rubella and Treponema pallidum infections in northern Benin,” Tropical Medicine & International Health, vol. 19, no. 6, pp. 743–746, 2014.

R. Kinoshita-moleka, J. S. Smith, J. Atibu et al., “Low prevalence of HIV and other selected sexually transmitted infections in 2004 in pregnant women from Kinshasa, the Democratic Republic of the Congo,” Epidemiology and Infection, vol. 136, no. 9, pp. 1290–1296, 2008.

M. M. Taylor, S. Ebrahim, N. Abiola et al., “Correlates of syphilis seropositivity and risk for syphilis-associated adverse pregnancy outcomes among women attending antenatal care clinics in the democratic Republic of Congo,” International Journal of STD & AIDS, vol. 25, no. 10, pp. 716–725, 2014.

M. Berrueta, M. L. Cafferata, M. Mwenechanya et al., “Syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cross-sectional study,” Gates Open Research, vol. 1, p. 13, 2017.

R. F. Niama, N. C. L. Bongolo, E. S. B. Kombo et al., “Syphilis and HIV infections among pregnant women attending antenatal clinics in Republic of Congo,” Pan African Medical Journal, vol. 28, no. 1, 2017.

S. K. Emmanuel, M. Lado, S. Amwayi, A. M. Abade, J. O. Oundo, and J. R. Ongus, “Syphilis among pregnant women in Juba, Southern Sudan,” East African Medical Journal, vol. 87, no. 5, pp. 192–198, 2010.

N. A. Abdelrahim, H. I. Ahmed, I. M. Fadl-Elmula, M. A. Bayoumi, and M. M. Homeida, “Sexually transmitted infections other than HIV/AIDS among women of low socio-economic class attending antenatal clinics in Khartoum, Sudan,” International Journal of STD & AIDS, vol. 28, no. 8, pp. 781–787, 2017.

S. M. Elkheir, Z. O. Babiker, S. K. Elamin et al., “Seroprevalence of maternal HIV, hepatitis B, and syphilis in a major maternity hospital in North Kordofan, Sudan,” International Journal of STD & AIDS, vol. 29, no. 13, pp. 1330–1336, 2018.

L. Pham, G. B. Woelk, Y. Ning et al., “Seroprevalence and risk factors of syphilis infection in pregnant women delivering at Harare Maternity Hospital, Zimbabwe,” Central African Journal of Medicine, vol. 51, no. 3-4, pp. 24–30, 2005.

N. E. Kurewa, M. P. Mapingure, M. W. Munjoma, M. Z. Chirenje, S. Rusakaniko, and B. Stray-Pedersen, “The burden and risk factors of sexually transmitted infections and reproductive tract infections among pregnant women in Zimbabwe,” BMC Infectious Diseases, vol. 10, no. 1, article no. 127, 2010.

J. Kwiek, V. Mwapasa, A. Alker et al., “Socio-demographic characteristics associated with HIV and syphilis seroreactivity among pregnant women in Blantyre, Malawi, 2000-2004,” Malawi Medical Journal, vol. 20, no. 3, pp. 80–85, 2008.

I. Sombié, N. Meda, M. Cartoux et al., “Seroprevalence of syphilis among women attending urban antenatal clinics in Burkina Faso, 1995–1998,” Sexually Transmitted Infections, vol. 76, no. 4, pp. 314–316, 2000.

F. Kirakoya-Samadoulougou, M. Defer, S. Yaro et al., “Low seroprevalence of syphilis in Burkina Faso,” Sexually Transmitted Infections, vol. 87, no. 1, pp. 35–37, 2011.

W. K. Urassa, S. H. Kapiga, G. I. Msamanga, G. Antelman, J. Coley, and W. W. Fawzi, “Risk factors for syphilis among HIV-1 infected pregnant women in Dar es Salaam, Tanzania,” African Journal of Reproductive Health, vol. 5, no. 3, pp. 54–62, 2001.

R. O. Swai, G. R. Somi G, M. I. Matee et al., “Surveillance of HIV and syphilis infections among antenatal clinic attendees in Tanzania-2003/2004,” BMC Public Health, vol. 6, no. 1, article no. 91, 2006.

K. I. Yahya-Malima, B. Evjen-Olsen, M. I. Matee, K. Fylkesnes, and L. Haarr, “HIV-1, HSV-2 and syphilis among pregnant women in a rural area of Tanzania: prevalence and risk factors,” BMC Infectious Diseases, vol. 8, no. 1, article no. 75, 2008.

J. Manyahi, B. S. Jullu, M. I. Abuya et al., “Prevalence of HIV and syphilis infections among pregnant women attending antenatal clinics in Tanzania, 2011,” BMC Public Health, vol. 15, no. 1, article no. 501, 2015.

J. D. Lawi, M. M. Mirambo, M. Magoma et al., “Sero-conversion rate of Syphilis and HIV among pregnant women attending antenatal clinic in Tanzania: a need for re-screening at delivery,” BMC Pregnancy and Childbirth, vol. 15, no. 1, article no. 3, 2015.

F. Månsson, C. Camara, A. Biai et al., “High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa,” International Journal of STD & AIDS, vol. 21, no. 9, pp. 631–635, 2010.

K. A. Apea-Kubi, S. Yamaguchi, B. Sakyi, T. Kisimoto, D. Ofori-Adjei, and T. Hagiwara, “Neisseria gonorrhoea, Chlamydia trachomatis, and Treponema pallidum infection in antenatal and gynecological patients at Korle-Bu Teaching Hospital, Ghana,” Japanese Journal of Infectious Diseases, vol. 57, no. 6, pp. 253–256, 2004.

D. Blankhart, O. Müller, G. Gresenguet, and P. Weis, “Sexually transmitted infections in young pregnant women in Bangui, Central African Republic,” International Journal of STD & AIDS, vol. 10, no. 9, pp. 609–614, 1999.

P. Gichangi, L. V. Renterghem, J. Karanja, J. Bwayo, D. Kiragu, and M. Temmerman, “Congenital syphilis in a Nairobi Maternity Hospital,” East African Medical Journal, vol. 81, no. 11, pp. 589–593, 2004.

G. Marx, G. John-Stewart, R. Bosire, D. Wamalwa, P. Otieno, and C. Farquhar, “Diagnosis of sexually transmitted infections and bacterial vaginosis among HIV-1-infected pregnant women in Nairobi,” International Journal of STD & AIDS, vol. 21, no. 8, pp. 549–552, 2010.

M. Romoren and M. Rahman, “Syphilis screening in the antenatal care: a cross-sectional study from Botswana,” BMC International Health and Human Rights, vol. 6, no. 1, article no. 8, 2006.

A. Kuznik, A. G. Habib, Y. C. Manabe, and M. Lamorde, “Estimating the public health burden associated with adverse pregnancy outcomes resulting from syphilis infection across 43 countries in sub-Saharan Africa,” Sexually Transmitted Diseases, vol. 42, no. 7, pp. 369–375, 2015.

R. M. Chico, P. Mayaud, C. Ariti, D. Mabey, C. Ronsmans, and D. Chandramohan, “Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review,” The Journal of the American Medical Association, vol. 307, no. 19, pp. 2079–2086, 2012.

F. G. Kouyoumdjian, D. Leto, S. John, H. Henein, and S. Bondy, “A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons,” International Journal of STD & AIDS, vol. 23, no. 4, pp. 248–254, 2012.

S. Graham, L. W. Smith, C. K. Fairley, and J. Hocking, “Prevalence of chlamydia, gonorrhoea, syphilis and trichomonas in Aboriginal and Torres Strait Islander Australians: a systematic review and meta-analysis,” Sexual Health, vol. 13, no. 2, pp. 99–113, 2016.

R. Hitimana, L. Lindholm, G. Krantz, M. Nzayirambaho, and A. Pulkki-Brännström, “Cost of antenatal care for the health sector and for households in Rwanda,” BMC Health Services Research, vol. 18, no. 1, aricle no. 262, 2018.

M. Kanyangarara, N. Walker, and T. Boerma, “Gaps in the implementation of antenatal syphilis detection and treatment in health facilities across sub-Saharan Africa,” PLoS ONE, vol. 13, no. 6, Article ID e0198622, 2018.

S. Ratnam, “The laboratory diagnosis of syphilis,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 16, no. 1, pp. 45–51, 2005.

S. A. Larsen, B. M. Steiner, and A. H. Rudolph, “Laboratory diagnosis and interpretation of tests for syphilis,” Clinical Microbiology Reviews, vol. 8, no. 1, pp. 1–21, 1995.